Publications by the researcher in collaboration with María Isabel González Álvarez (67)

2024

  1. In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug

    Pharmaceutics, Vol. 16, Núm. 3

  2. Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole

    Pharmaceutics, Vol. 16, Núm. 5

2022

  1. Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen

    International Journal of Pharmaceutics, Vol. 614

2021

  1. Nuevos hidrogeles para favorecer la cicatrización

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 175-176

2020

  1. Candesartan cilexetil in vitro–in vivo correlation: Predictive dissolution as a development tool

    Pharmaceutics, Vol. 12, Núm. 7, pp. 1-21

  2. New insights of oral colonic drug delivery systems for inflammatory bowel disease therapy

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-30

2019

  1. Covalently crosslinked organophosphorous derivatives-chitosan hydrogel as a drug delivery system for oral administration of camptothecin

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 136, pp. 174-183

  2. Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease

    Molecular Pharmaceutics, Vol. 16, Núm. 6, pp. 2418-2429

  3. Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug

    International Journal of Pharmaceutics, Vol. 557, pp. 36-42

2018

  1. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat—Biophysical Model and Predictions Based on Caco-2

    Pharmaceutical Research, Vol. 35, Núm. 1

  2. Ionic Hydrogel Based on Chitosan Cross-Linked with 6-Phosphogluconic Trisodium Salt as a Drug Delivery System

    Biomacromolecules, Vol. 19, Núm. 4, pp. 1294-1304

  3. Long-circulating hyaluronan-based nanohydrogels as carriers of hydrophobic drugs

    Pharmaceutics, Vol. 10, Núm. 4

  4. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen

    European Journal of Pharmaceutical Sciences, Vol. 115, pp. 119-125

  5. Preclinical models for colonic absorption, application to controlled release formulation development

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 130, pp. 247-259

  6. Smart gated magnetic silica mesoporous particles for targeted colon drug delivery: New approaches for inflammatory bowel diseases treatment

    Journal of Controlled Release, Vol. 281, pp. 58-69

2017

  1. Comparison of segmental-dependent permeability in human and in situ perfusion model in rat

    European Journal of Pharmaceutical Sciences, Vol. 107, pp. 191-196

  2. Enhancing Oral Absorption of β-Lapachone: Progress Till Date

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 42, Núm. 1

  3. Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 135-141

  4. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B coculture models to predict intestinal and colonic permeability compared to Caco-2 monoculture

    Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1264-1270

2016

  1. Assessment of the Regulatory Methods for the Comparison of Highly Variable Dissolution Profiles

    AAPS Journal, Vol. 18, Núm. 6, pp. 1550-1561